Close the acquisition of Reata Pharmaceuticals
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 28 Jul 2023
- Due
- 31 Dec 2023
- Delivered
- 26 Sep 2023
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“The transaction, which was approved by the boards of directors of both companies, is currently anticipated to close in the fourth quarter of 2023.”
What we found
Evidence strength A What the grades mean
Biogen completed the acquisition of Reata on September 26, 2023, ahead of the guided fourth quarter 2023 close.
-
A Biogen 10-K filed 2024-02-14
“On September 26, 2023, we completed the acquisition of all of the issued and outstanding shares of Reata” ✓ confirmed on the page
-
A Biogen 10-Q filed 2024-10-30
“On September 26, 2023, we completed the acquisition of all of the issued and outstanding shares of Reata” ✓ confirmed on the page
Market reaction: the shares moved -4.4% against the S&P 500 over the three sessions around the disclosure (13 Feb 2024 to 16 Feb 2024). What this measures
Checked 10 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Acquisition close
- Indicative materiality
- High rules
- Action
- Close
- Deliverable
- Acquisition of Reata Pharmaceuticals
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: approval by Reata stockholders; receipt of necessary regulatory approvals
- Depends on
- Regulatory, Shareholder
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Biogen? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2023-BIIB-005355 · Corrections policy